Viewing StudyNCT05132504



Ignite Creation Date: 2024-05-06 @ 4:56 PM
Last Modification Date: 2024-10-26 @ 2:18 PM
Study NCT ID: NCT05132504
Status: RECRUITING
Last Update Posted: 2024-02-15
First Post: 2021-10-27

Brief Title: Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer
Sponsor: Baylor College of Medicine
Organization: Baylor College of Medicine

Conditions & Keywords Data

Conditions:
Name
Pancreatic Ductal Adenocarcinoma
Keywords:
Name View
folfirinox View
pembrolizumab View
pancreatic cancer View
pancreas adenocarcinoma View